[Challenges and countermeasures of schistosomiasis control in Hunan Province in the new era].

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi

Hunan Institute of Parasitic Diseases, WHO Collaborating Center on Schistosomiasis Control in Lake Regions, Hunan Key Laboratory of Immunology and Transmission Control of Schistosomiasis, National Key Clinical Specialty, Yueyang 414000, China.

Published: April 2020

This paper describes the current epidemic characteristics and endemic status of schistosomiasis, analyzes the main challenges of schistosomiasis control and proposes the emphasis and interventions for future schistosomiasis control activities in Hunan Province, so as to provide insights into the elimination of schistosomiasis in Hunan Province.

Download full-text PDF

Source
http://dx.doi.org/10.16250/j.32.1374.2020051DOI Listing

Publication Analysis

Top Keywords

schistosomiasis control
12
hunan province
12
schistosomiasis
5
[challenges countermeasures
4
countermeasures schistosomiasis
4
control hunan
4
province era]
4
era] paper
4
paper describes
4
describes current
4

Similar Publications

In vitro antischistosomal activity of Artemisia species.

Acta Trop

January 2025

Centre of Excellence for Pharmaceutical Sciences (Pharmacen(TM)), North-West University, Private Bag X6001, Potchefstroom 2520, South Africa. Electronic address:

Praziquantel is currently the only effective treatment for schistosomiasis, but several limitations underscore the need for new therapeutic agents. Recent promising in vitro results with Artemisia species and the success of A. annua and its active compound artemisinin in treating parasitic infections warrant the need for further studies.

View Article and Find Full Text PDF

Fascioliasis and schistosomiasis are parasitic trematodiases of public health and economic concern in humans and livestock. However, data on the distribution and risk factors for fascioliasis remain limited, while epidemiological gaps hinder schistosomiasis control in Tanzania. This One Health, cross-sectional study examined the prevalence and risk factors of schistomiasis and fascioliasis in northern Tanzania, involving 310 livestock and 317 human participants from Arusha, Kilimanjaro, and Manyara regions.

View Article and Find Full Text PDF

Antibody Responses and the Vaccine Efficacy of Recombinant Glycosyltransferase and Nicastrin Against .

Pathogens

January 2025

National Reference Laboratory for Animal Schistosomiasis, Key Laboratory of Animal Parasitology of Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, China.

Schistosomiasis is a neglected tropical disease and the second most common parasitic disease after malaria. While praziquantel remains the primary treatment, concerns about drug resistance highlight the urgent need for new drugs and effective vaccines to achieve sustainable control. Previous proteomic studies from our group revealed that the expression of glycosyltransferase and nicastrin as proteins was higher in single-sex males than mated males, suggesting their critical roles in parasite reproduction and their potential as vaccine candidates.

View Article and Find Full Text PDF

Effect of Praziquantel on Preventing Delayed Infection of in Buffaloes and Goats.

Microorganisms

December 2024

National Reference Laboratory for Animal Schistosomiasis, Key Laboratory of Animal Parasitology of Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, China.

Schistosomiasis, caused by , continues to pose a major public health threat in East Asia, with an estimated 71 million people at risk of infection. Domestic animals, especially buffaloes and goats, serve as important reservoir hosts, facilitating the transmission of the parasite to humans. While praziquantel (PZQ) is the first-line treatment for schistosomiasis due to its broad-spectrum efficacy against adult schistosomes, its prophylactic potential is less explored.

View Article and Find Full Text PDF

Background: Schistosoma haematobium is the causative pathogen for urogenital schistosomiasis. To achieve progress towards schistosomiasis elimination, there is a critical need for developing highly sensitive and specific tools to monitor transmission in near-elimination settings. Although antibody detection is a promising approach, it is usually unable to discriminate active infections from past ones.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!